Form 4: BioCardia CEO Peter Altman Increases Stake in Company
SEC Form 4 Filing
BioCardia's CEO, Peter Altman, recently purchased 500 shares of the company's common stock at an average price of $2.11 per share.
Summary
- On March 3, 2025, Peter Altman, the President and CEO of BioCardia, Inc., acquired 500 shares of common stock.
- The shares were purchased at a weighted average price of $2.11 per share, with individual trades ranging from $2.05 to $2.15.
- Following this transaction, Altman directly owns 108,420 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase is a positive signal, but the small number of shares purchased doesn't suggest overwhelming confidence.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The CEO's stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of transaction: Peter Altman purchased 500 shares of BioCardia common stock. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.